Biotech news continually updated from thousands of sources around the net.
1 hr ago | Heraldseries.co.uk
The county's economy grew by 3.5 per cent last year, compared with the national rate of 3.2 per cent, making it the second-best-performing area in the south east.
2 hrs ago | PhysOrg Weblog
Safety trials on an Ebola vaccine are being fast-tracked, meaning it could be given to healthy volunteers as early as September, researchers said Thursday.
Roche Holding AG's planned $8 billion purchase of InterMune Inc is centered around hopes for blockbuster sales of its lung drug, but the smaller company's development pipeline may end up giving the Swiss drugmaker a far bigger bang for its buck.
A supply chain and logistics company has taken a nearly 10 percent stake in Medifast over the last month - and left open the door to buying more.
A Centers for Disease Control and Prevention staff member has returned to the United States from West Africa by charter flight after the employee had low-risk contact with a health worker who tested positive for Ebola.
You might think that a company called Isis Pharmaceuticals would be itching to change its name in order to avoid confusion with the terrorist organization Islamic State of Iraq and Syria .
U.S. stock index futures pointed to a flat open on Wednesday, as investors found few reasons to keep buying after a rally that has taken indexes to repeated records, even as there was little seen on the horizon that could derail the rally.
Glaucoma, caused by rising fluid pressure in the eyes, is known as the silent thief of sight.
As a whole, it is the heart of innovation within the IDEXX Corporation, and successfully concludes Phase II of the master plan crafted by Lavallee Brensinger Architects of , Principal-In-Charge at Lavallee Brensinger, IDEXX made its design objectives for the new 108,000 square foot building clear from the start.
Allergan Inc said on Tuesday that it has scheduled a special shareholders meeting for Dec. 18, when activist investor Bill Ackman, who supports a hostile bid for the company by Valeant Pharmaceuticals Inc, will attempt to oust most of its board.
I mean, just look at these returns: Gilead Sciences has gained 41% so far this year as investors appear to have put their Sovaldi worries behind them ; InterMune has quintupled in 2014 after Roche agreed to purchase it for $8.3 billion ; and Intercept Pharmaceuticals has surged 350% as drug trials have been surprisingly good .
Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in the hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy.
Swiss pharmaceutical company Roche Holding has agreed to buy US biotech company InterMune for $8.3 billion in cash in order to get hold of a promising respiratory drug, in the latest multibillion-dollar deal in a consolidating pharmaceutical and biotechnology sector.
Despite a groundswell of opposition from watchdog groups, doctors, scientists, 50 members of Congress and thousands of members of the general public, the U.S. Department of Agriculture has decided to move forward with approval for three new genetically modified crops designed to be sprayed with Dow AgroScience's Enlist Duo herbicide, which contains ... (more)
The significance of the milestone was more psychological than fundamental, and it represents the high point of a nearly six-year rally that has boosted retirement accounts for Americans from Wall Street to Main Street, though the gains have largely benefited wealthier Americans.
Latest numbers from the CDC cite more than 2,600 cases of Ebola and 1,400 deaths reported in Guinea, Liberia, Nigeria and Sierra Leone, the four countries affected by the outbreak thus far.
Updated: Thu Aug 28, 2014 07:04 am
Copyright © 2014 Topix LLC